8-K Announcements
6Material company update
Apr 9, 2026·SEC
Material company update
Mar 17, 2026·SEC
Material company update
Mar 12, 2026·SEC
Colgate-Palmolive Company(CL)Earnings, Financials & Key Ratios
CL•NYSE
34.0× P/E·Price updated Jun 19, 2026
AboutColgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.Show more
- Revenue$20.38B+1.4%
- EBITDA$4.98B-0.2%
- Net Income$2.13B-26.2%
- EPS (Diluted)2.63-25.1%
- Gross Margin60.11%-0.2%
- EBITDA Margin24.42%-1.6%
- Operating Margin21.33%-2.2%
- Net Margin10.46%-27.2%
- ROE469.09%+21.9%
CL Key Insights
Colgate-Palmolive Company (CL) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Dividend Aristocrat: 53 years of consecutive increases
- ✓Excellent 3Y average ROE of 371.6%
- ✓FCF machine: 17.8% free cash flow margin
- ✓High quality earnings: Operating CF exceeds net income
- ✓Healthy dividend yield of 2.5%
- ✓Healthy 5Y average net margin of 11.8%
✗Weaknesses
- ✗High debt to equity ratio of 21.9x
- ✗Expensive at 198.8x book value
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when CL posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
CL Price & Volume
Colgate-Palmolive Company (CL) stock price & volume — 10-year historical chart
Loading chart...
CL Growth Metrics
Colgate-Palmolive Company (CL) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years2.43%
5 Years4.35%
3 Years4.29%
TTM1.4%
Profit CAGR
10 Years4.42%
5 Years-4.58%
3 Years6.1%
TTM-26.26%
EPS CAGR
10 Years5.64%
5 Years-3.48%
3 Years7.28%
TTM-25.45%
Return on Capital
10 Years38.86%
5 Years36.61%
3 Years38.98%
Last Year41.65%
CL Recent Earnings
Colgate-Palmolive Company (CL) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 12/12 qtrs (100%)●Beat Revenue 11/12 qtrs (92%)
Q2 2026Latest
May 1, 2026Metric
Actual
Est
EPS
$0.97+2.9%
$0.94
Rev
$5.3B+2.1%
$5.2B
Q1 2026
Jan 30, 2026Metric
Actual
Est
EPS
$0.95+4.2%
$0.91
Rev
$5.2B+2.1%
$5.1B
Q4 2025
Oct 31, 2025Metric
Actual
Est
EPS
$0.91+2.4%
$0.89
Rev
$5.1B+0.1%
$5.1B
Q3 2025
Aug 1, 2025Metric
Actual
Est
EPS
$0.92+2.6%
$0.90
Rev
$5.1B+1.5%
$5.0B
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 1, 2026 | $0.97vs $0.94+2.9% | $5.3Bvs $5.2B+2.1% |
| Q1 2026 | Jan 30, 2026 | $0.95vs $0.91+4.2% | $5.2Bvs $5.1B+2.1% |
| Q4 2025 | Oct 31, 2025 | $0.91vs $0.89+2.4% | $5.1Bvs $5.1B+0.1% |
| Q3 2025 | Aug 1, 2025 | $0.92vs $0.90+2.6% | $5.1Bvs $5.0B+1.5% |
Based on last 12 quarters of dataView full earnings history →
CL Peer Comparison
Colgate-Palmolive Company (CL) competitors in Personal Care and Beauty Products — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 PG | 351.4B | 150.38 | 23.10 | 0.29% | 14.66% | 23.78% | 0.68 | |
 UL | 127.6B | 58.40 | 22.16 | 1.94% | 10.16% | 61.19% | 1.36 | |
 KMB | 34.04B | 102.56 | 16.90 | -14.17% | 12.81% | 131.68% | 4.34 | |
 CHD | 22.65B | 95.64 | 31.67 | 1.57% | 11.81% | 17.45% | 0.55 | |
 ENR | 1.47B | 21.52 | 6.48 | 2.28% | 6.55% | 116.9% | 20.79 | |
 COTY | 1.72B | 1.95 | -4.43 | -3.68% | -9.26% | -14.13% | 1.07 | |
 ELF | 3.82B | 64.20 | 145.91 | 24.59% | 3.34% | 5.16% | 0.81 | |
 PRGO | 1.42B | 10.25 | -1.00 | -2.75% | -43.5% | -50.65% | 1.35 |
Compare CL vs Peers
Colgate-Palmolive Company (CL) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
CL Income Statement
Colgate-Palmolive Company (CL) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 15.45B | 15.54B | 15.69B | 16.47B | 17.42B | 17.97B | 19.46B | 20.1B | 20.38B |
Revenue Growth % | 1.7% | 0.58% | 0.96% | 4.96% | 5.77% | 3.13% | 8.29% | 3.31% | 1.4% |
Cost of Goods Sold | 6.13B | 6.34B | 6.42B | 6.54B | 7.13B | 7.82B | 8.21B | 8B | 8.13B |
COGS % of Revenue | 39.67% | 40.77% | 40.88% | 39.69% | 40.92% | 43.51% | 42.18% | 39.77% | 39.89% |
Gross Profit | 9.32B▲ 0% | 9.21B▼ 1.3% | 9.28B▲ 0.8% | 9.93B▲ 7.1% | 10.29B▲ 3.6% | 10.15B▼ 1.4% | 11.25B▲ 10.8% | 12.11B▲ 7.6% | 12.25B▲ 1.2% |
Gross Margin % | 60.33% | 59.23% | 59.12% | 60.31% | 59.08% | 56.49% | 57.82% | 60.23% | 60.11% |
Gross Profit Growth % | 2.09% | -1.26% | 0.77% | 7.07% | 3.62% | -1.39% | 10.85% | 7.6% | 1.2% |
Operating Expenses | 5.31B | 5.36B | 5.51B | 6.02B | 6.41B | 6.57B | 7.12B | 7.72B | 7.9B |
OpEx % of Revenue | 34.39% | 34.46% | 35.14% | 36.56% | 36.78% | 36.54% | 36.59% | 38.42% | 38.77% |
Selling, General & Admin | 5.03B | 5.08B | 5.23B | 5.73B | 6.1B | 6.25B | 6.78B | 7.81B | 7.9B |
SG&A % of Revenue | 32.54% | 32.67% | 33.35% | 34.8% | 35.02% | 34.76% | 34.83% | 38.85% | 38.77% |
Research & Development | 285M | 277M | 281M | 290M | 307M | 320M | 343M | 355M | 0 |
R&D % of Revenue | 1.84% | 1.78% | 1.79% | 1.76% | 1.76% | 1.78% | 1.76% | 1.77% | - |
Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -442M | 0 |
Operating Income | 4.01B▲ 0% | 3.85B▼ 4.0% | 3.76B▼ 2.3% | 3.91B▲ 4.0% | 3.89B▼ 0.6% | 3.58B▼ 7.7% | 4.13B▲ 15.2% | 4.38B▲ 6.1% | 4.35B▼ 0.8% |
Operating Margin % | 25.94% | 24.77% | 23.97% | 23.74% | 22.31% | 19.95% | 21.23% | 21.8% | 21.33% |
Operating Income Growth % | 1.24% | -3.97% | -2.29% | 3.96% | -0.64% | -7.75% | 15.23% | 6.1% | -0.8% |
EBITDA | 4.48B | 4.36B | 4.28B | 4.45B | 4.44B | 4.13B | 4.7B | 4.99B | 4.98B |
EBITDA Margin % | 29.02% | 28.06% | 27.28% | 27.02% | 25.5% | 22.99% | 24.15% | 24.81% | 24.42% |
EBITDA Growth % | 1.84% | -2.74% | -1.83% | 3.95% | -0.18% | -7.02% | 13.75% | 6.17% | -0.2% |
D&A (Non-Cash Add-back) | 475M | 511M | 519M | 539M | 556M | 545M | 567M | 605M | 630M |
EBIT | 3.64B | 3.66B | 3.49B | 3.81B | 3.2B | 2.83B | 3.68B | 4.25B | 3.33B |
Net Interest Income | -102M | -143M | -145M | -141M | -100M | -153M | -232M | -225M | -192M |
Interest Income | 51M | 50M | 47M | 19M | 17M | 14M | 55M | 67M | 75M |
Interest Expense | 153M | 193M | 192M | 160M | 117M | 167M | 287M | 292M | 267M |
Other Income/Expense | -522M | -386M | -461M | -264M | -799M | -925M | -739M | -427M | -1.29B |
Pretax Income | 3.49B▲ 0% | 3.46B▼ 0.7% | 3.3B▼ 4.7% | 3.65B▲ 10.5% | 3.09B▼ 15.4% | 2.66B▼ 13.8% | 3.39B▲ 27.5% | 3.96B▲ 16.6% | 3.06B▼ 22.7% |
Pretax Margin % | 22.56% | 22.29% | 21.03% | 22.14% | 17.72% | 14.8% | 17.43% | 19.68% | 15.01% |
Income Tax | 1.31B | 906M | 774M | 787M | 749M | 693M | 937M | 907M | 798M |
Effective Tax Rate % | 37.65% | 26.15% | 23.45% | 21.58% | 24.26% | 26.05% | 27.62% | 22.93% | 26.09% |
Net Income | 2.02B▲ 0% | 2.4B▲ 18.6% | 2.37B▼ 1.4% | 2.69B▲ 13.9% | 2.17B▼ 19.6% | 1.78B▼ 17.6% | 2.3B▲ 28.9% | 2.89B▲ 25.6% | 2.13B▼ 26.2% |
Net Margin % | 13.1% | 15.44% | 15.08% | 16.36% | 12.43% | 9.93% | 11.82% | 14.37% | 10.46% |
Net Income Growth % | -17.08% | 18.58% | -1.38% | 13.86% | -19.63% | -17.59% | 28.85% | 25.61% | -26.2% |
Net Income (Continuing) | 2.17B | 2.56B | 2.53B | 2.86B | 2.34B | 1.97B | 2.46B | 3.05B | 2.26B |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 303M | 299M | 441M | 358M | 362M | 405M | 348M | 332M | 311M |
EPS (Diluted) | 2.28▲ 0% | 2.75▲ 20.6% | 2.75▲ 0.0% | 3.14▲ 14.2% | 2.55▼ 18.8% | 2.13▼ 16.5% | 2.77▲ 30.0% | 3.51▲ 26.7% | 2.63▼ 25.1% |
EPS Growth % | -16.18% | 20.61% | 0% | 14.18% | -18.79% | -16.47% | 30.05% | 26.71% | -25.07% |
EPS (Basic) | 2.30 | 2.76 | 2.76 | 3.15 | 2.56 | 2.13 | 2.78 | 3.53 | 2.64 |
Diluted Shares Outstanding | 887.8M | 873M | 861.1M | 859.3M | 848.3M | 838.8M | 829.2M | 822.5M | 811.1M |
Basic Shares Outstanding | 881.8M | 870.6M | 859.1M | 856.8M | 845M | 836.4M | 827.4M | 817.7M | 808.7M |
Dividend Payout Ratio | 75.54% | 66.29% | 68.19% | 55.73% | 77.52% | 94.73% | 76.04% | 61.92% | 85.51% |
CL Balance Sheet
Colgate-Palmolive Company (CL) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 4.64B | 3.79B | 4.18B | 4.34B | 4.4B | 5.11B | 5.28B | 5.32B | 5.71B |
Cash & Short-Term Investments | 1.53B | 726M | 883M | 888M | 832M | 775M | 966M | 1.26B | 1.29B |
Cash Only | 1.53B | 726M | 883M | 888M | 832M | 775M | 966M | 1.1B | 1.29B |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 160M | 0 |
Accounts Receivable | 1.48B | 1.4B | 1.44B | 1.26B | 1.3B | 1.5B | 1.59B | 1.52B | 1.68B |
Days Sales Outstanding | 34.96 | 32.87 | 33.49 | 28.01 | 27.17 | 30.55 | 29.75 | 27.62 | 30 |
Inventory | 1.22B | 1.25B | 1.4B | 1.67B | 1.69B | 2.07B | 1.93B | 1.99B | 2.03B |
Days Inventory Outstanding | 72.69 | 71.99 | 79.64 | 93.4 | 86.64 | 96.84 | 86.02 | 90.71 | 91.22 |
Other Current Assets | 403M | 417M | 456M | 513M | 576M | 760M | 793M | 553M | 714M |
Total Non-Current Assets | 8.04B | 8.37B | 10.86B | 11.58B | 10.64B | 10.62B | 11.11B | 10.73B | 10.62B |
Property, Plant & Equipment | 4.07B | 3.88B | 3.75B | 3.72B | 3.73B | 4.31B | 4.58B | 4.42B | 4.66B |
Fixed Asset Turnover | 3.80x | 4.01x | 4.18x | 4.43x | 4.67x | 4.17x | 4.25x | 4.55x | 4.37x |
Goodwill | 2.22B | 2.53B | 3.51B | 3.82B | 3.28B | 3.35B | 3.41B | 3.27B | 3.12B |
Intangible Assets | 1.34B | 1.64B | 2.67B | 2.89B | 2.46B | 1.92B | 1.89B | 1.76B | 1.54B |
Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 81M | 0 |
Other Non-Current Assets | 218M | 168M | 753M | 857M | 974M | 904M | 1.02B | 1B | 1.3B |
Total Assets | 12.68B▲ 0% | 12.16B▼ 4.1% | 15.03B▲ 23.6% | 15.92B▲ 5.9% | 15.04B▼ 5.5% | 15.73B▲ 4.6% | 16.39B▲ 4.2% | 16.05B▼ 2.1% | 16.33B▲ 1.8% |
Asset Turnover | 1.22x | 1.28x | 1.04x | 1.03x | 1.16x | 1.14x | 1.19x | 1.25x | 1.25x |
Asset Growth % | 4.56% | -4.06% | 23.62% | 5.89% | -5.53% | 4.59% | 4.21% | -2.12% | 1.77% |
Total Current Liabilities | 3.41B | 3.34B | 4.04B | 4.4B | 4.05B | 4B | 4.74B | 5.76B | 5.74B |
Accounts Payable | 1.21B | 1.22B | 1.24B | 1.39B | 1.48B | 1.55B | 1.7B | 1.8B | 0 |
Days Payables Outstanding | 72.15 | 70.37 | 70.37 | 77.77 | 75.73 | 72.42 | 75.53 | 82.4 | - |
Short-Term Debt | 11M | 12M | 514M | 267M | 51M | 25M | 330M | 660M | 0 |
Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 101M | 93M | 70M | 182M | 93M | 97M | 122M | 116M | 5.74B |
Current Ratio | 1.36x | 1.14x | 1.03x | 0.99x | 1.09x | 1.28x | 1.11x | 0.92x | 1.00x |
Quick Ratio | 1.00x | 0.76x | 0.69x | 0.61x | 0.67x | 0.76x | 0.71x | 0.58x | 0.64x |
Cash Conversion Cycle | 35.49 | 34.49 | 42.77 | 43.64 | 38.08 | 54.97 | 40.25 | 35.93 | - |
Total Non-Current Liabilities | 9.03B | 8.62B | 10.44B | 10.41B | 10.02B | 10.92B | 10.7B | 9.74B | 10.23B |
Long-Term Debt | 6.57B | 6.35B | 7.33B | 7.33B | 7.19B | 8.74B | 8.22B | 7.29B | 7.99B |
Capital Lease Obligations | 0 | 0 | 491M | 476M | 451M | 397M | 420M | 456M | 0 |
Deferred Tax Liabilities | 204M | 235M | 507M | 426M | 395M | 383M | 361M | 343M | 0 |
Other Non-Current Liabilities | 2.25B | 2.03B | 2.11B | 2.18B | 1.98B | 1.4B | 1.7B | 1.66B | 2.24B |
Total Liabilities | 12.43B | 11.96B | 14.48B | 14.82B | 14.07B | 14.93B | 15.44B | 15.5B | 15.96B |
Total Debt | 6.58B | 6.37B | 8.48B | 8.21B | 7.83B | 9.27B | 9.06B | 8.51B | 7.99B |
Net Debt | 5.04B | 5.64B | 7.6B | 7.33B | 7B | 8.5B | 8.1B | 7.42B | 6.7B |
Debt / Equity | 27.07x | 32.31x | 15.20x | 7.46x | 8.07x | 11.50x | 9.47x | 15.65x | 21.88x |
Debt / EBITDA | 1.47x | 1.46x | 1.98x | 1.85x | 1.76x | 2.24x | 1.93x | 1.71x | 1.60x |
Net Debt / EBITDA | 1.12x | 1.29x | 1.78x | 1.65x | 1.58x | 2.06x | 1.72x | 1.49x | 1.35x |
Interest Coverage | 23.79x | 18.95x | 18.19x | 23.79x | 27.38x | 16.93x | 12.82x | 14.55x | 12.46x |
Total Equity | 243M▲ 0% | 197M▼ 18.9% | 558M▲ 183.2% | 1.1B▲ 97.3% | 971M▼ 11.8% | 806M▼ 17.0% | 957M▲ 18.7% | 544M▼ 43.2% | 365M▼ 32.9% |
Equity Growth % | 1329.41% | -18.93% | 183.25% | 97.31% | -11.81% | -16.99% | 18.73% | -43.16% | -32.9% |
Book Value per Share | 0.27 | 0.23 | 0.65 | 1.28 | 1.14 | 0.96 | 1.15 | 0.66 | 0.45 |
Total Shareholders' Equity | -60M | -102M | 117M | 743M | 609M | 401M | 609M | 212M | 54M |
Common Stock | 1.47B | 1.47B | 1.47B | 1.47B | 1.47B | 1.47B | 1.47B | 1.47B | 0 |
Retained Earnings | 20.53B | 21.61B | 22.5B | 23.7B | 24.35B | 24.57B | 25.29B | 26.14B | 0 |
Treasury Stock | -20.18B | -21.2B | -22.06B | -23.05B | -24.09B | -25.13B | -26.02B | -27.36B | 0 |
Accumulated OCI | -3.85B | -4.19B | -4.27B | -4.34B | -4.39B | -4.05B | -3.94B | -4.22B | 0 |
Minority Interest | 303M | 299M | 441M | 358M | 362M | 405M | 348M | 332M | 311M |
CL Cash Flow Statement
Colgate-Palmolive Company (CL) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 3.05B | 3.06B | 3.13B | 3.72B | 3.33B | 2.56B | 3.75B | 4.11B | 4.2B |
Operating CF Margin % | 19.76% | 19.66% | 19.96% | 22.58% | 19.09% | 14.23% | 19.25% | 20.43% | 20.6% |
Operating CF Growth % | -2.77% | 0.07% | 2.52% | 18.7% | -10.59% | -23.13% | 46.52% | 9.67% | 2.22% |
Net Income | 2.17B | 2.56B | 2.53B | 2.86B | 2.34B | 1.97B | 2.46B | 3.05B | 2.13B |
Depreciation & Amortization | 475M | 511M | 519M | 539M | 556M | 545M | 567M | 605M | 630M |
Stock-Based Compensation | 127M | 109M | 100M | 107M | 135M | 125M | 122M | 135M | 0 |
Deferred Taxes | 383M | 107M | 17M | -120M | -132M | -78M | -98M | -77M | -109M |
Other Non-Cash Items | 10M | -74M | -95M | -48M | 625M | 723M | 244M | 51M | 1.26B |
Working Capital Changes | -115M | -155M | 65M | 381M | -197M | -726M | 455M | 344M | 284M |
Change in Receivables | -15M | -79M | 19M | 138M | -84M | -227M | -37M | -56M | -16M |
Change in Inventory | -8M | -58M | -77M | -251M | -72M | -333M | 194M | -100M | 109M |
Change in Payables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 516M | 251M |
Cash from Investing | -471M | -1.17B | -2.1B | -878M | -592M | -1.6B | -742M | -534M | -817M |
Capital Expenditures | -553M | -436M | -335M | -410M | -567M | -696M | -705M | -561M | -564M |
CapEx % of Revenue | 3.58% | 2.8% | 2.13% | 2.49% | 3.25% | 3.87% | 3.62% | 2.79% | 2.77% |
Acquisitions | 0 | -728M | -1.71B | -452M | 0 | -809M | 0 | 0 | -293M |
Investments | - | - | - | - | - | - | - | - | - |
Other Investing | 38M | 7M | 0 | 3M | -25M | 52M | -33M | 37M | -14M |
Cash from Financing | -2.45B | -2.68B | -870M | -2.82B | -2.77B | -952M | -2.79B | -3.39B | -3.26B |
Debt Issued (Net) | -29M | -179M | 1.43B | -564M | -175M | 1.65B | -314M | -408M | -456M |
Equity Issued (Net) | -1.4B | -1.24B | -1.2B | -602M | -1.32B | -1.31B | -1.13B | -1.74B | -1.11B |
Dividends Paid | -1.53B | -1.59B | -1.61B | -1.5B | -1.68B | -1.69B | -1.75B | -1.79B | -1.82B |
Share Repurchases | -1.4B | -1.24B | -1.2B | -1.48B | -1.32B | -1.31B | -1.13B | -1.74B | -1.21B |
Other Financing | 507M | 329M | 513M | -152M | 400M | 400M | 398M | 547M | 132M |
Net Change in Cash | 220M▲ 0% | -809M▼ 467.7% | 157M▲ 119.4% | 5M▼ 96.8% | -56M▼ 1220.0% | -57M▼ 1.8% | 191M▲ 435.1% | 130M▼ 31.9% | 192M▲ 47.7% |
Free Cash Flow | 2.5B▲ 0% | 2.62B▲ 4.8% | 2.8B▲ 6.8% | 3.31B▲ 18.3% | 2.76B▼ 16.7% | 1.86B▼ 32.6% | 3.04B▲ 63.4% | 3.55B▲ 16.6% | 3.63B▲ 2.5% |
FCF Margin % | 16.18% | 16.86% | 17.83% | 20.09% | 15.83% | 10.35% | 15.62% | 17.64% | 17.83% |
FCF Growth % | -1.84% | 4.76% | 6.79% | 18.26% | -16.65% | -32.56% | 63.44% | 16.64% | 2.48% |
FCF per Share | 2.82 | 3.00 | 3.25 | 3.85 | 3.25 | 2.22 | 3.67 | 4.31 | 4.48 |
FCF Conversion (FCF/Net Income) | 1.51x | 1.27x | 1.32x | 1.38x | 1.54x | 1.43x | 1.63x | 1.42x | 1.97x |
Interest Paid | 150M | 194M | 185M | 188M | 194M | 151M | 280M | 302M | 0 |
Taxes Paid | 1.04B | 847M | 803M | 845M | 890M | 945M | 937M | 933M | 0 |
CL Key Ratios
Colgate-Palmolive Company (CL) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | 14358.82% | 1556.92% | 1090.91% | 627.02% | 324.89% | 209.07% | 200.9% | 260.92% | 384.94% | 469.09% |
Return on Invested Capital (ROIC) | 55.16% | 57.16% | 51.92% | 40.32% | 35.37% | 35.54% | 31.13% | 33.76% | 38.64% | 43.41% |
Gross Margin | 60.1% | 60.33% | 59.23% | 59.12% | 60.31% | 59.08% | 56.49% | 57.82% | 60.23% | 60.11% |
Net Margin | 16.06% | 13.1% | 15.44% | 15.08% | 16.36% | 12.43% | 9.93% | 11.82% | 14.37% | 10.46% |
Debt / Equity | 384.29x | 27.07x | 32.31x | 15.20x | 7.46x | 8.07x | 11.50x | 9.47x | 15.65x | 21.88x |
Interest Coverage | 26.09x | 23.79x | 18.95x | 18.19x | 23.79x | 27.38x | 16.93x | 12.82x | 14.55x | 12.46x |
FCF Conversion | 1.29x | 1.51x | 1.27x | 1.32x | 1.38x | 1.54x | 1.43x | 1.63x | 1.42x | 1.97x |
Revenue Growth | -5.23% | 1.7% | 0.58% | 0.96% | 4.96% | 5.77% | 3.13% | 8.29% | 3.31% | 1.4% |
Related:CL Dividend History·CL Revenue History·CL Price History·CL P/E History·CL Financial Ratios·CL Institutional Holders
CL SEC Filings & Documents
Colgate-Palmolive Company (CL) SEC filings — annual & quarterly reports (10-K, 10-Q)
CL Frequently Asked Questions
Colgate-Palmolive Company (CL) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Colgate-Palmolive Company (CL) reported $20.38B in revenue for fiscal year 2025. This represents a 133% increase from $8.75B in 1996.
Colgate-Palmolive Company (CL) grew revenue by 1.4% over the past year. Growth has been modest.
Yes, Colgate-Palmolive Company (CL) is profitable, generating $2.13B in net income for fiscal year 2025 (10.5% net margin).
Dividend & Returns
Yes, Colgate-Palmolive Company (CL) pays a dividend with a yield of 2.51%. This makes it attractive for income-focused investors.
Colgate-Palmolive Company (CL) has a return on equity (ROE) of 469.1%. This is excellent, indicating efficient use of shareholder capital.
Colgate-Palmolive Company (CL) generated $3.63B in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.